NASDAQ:GTH Genetron (GTH) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free GTH Stock Alerts $4.03 +0.01 (+0.25%) (As of 03/28/2024) Add Compare Share Share Today's Range$4.02▼$4.0550-Day Range$3.80▼$4.0352-Week Range$2.08▼$4.05Volume412,600 shsAverage Volume51,662 shsMarket Capitalization$127.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Genetron alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Genetron Stock (NASDAQ:GTH)Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.Read More GTH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GTH Stock News HeadlinesApril 23, 2024 | americanbankingnews.comGenetron (NASDAQ:GTH) Trading Up 0.2%March 29, 2024 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Announces Completion of Going Private TransactionApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 28, 2024 | globenewswire.comGenetron Health Announces Completion of Going Private TransactionFebruary 21, 2024 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Announces Shareholders' Approval of Merger AgreementFebruary 21, 2024 | finance.yahoo.comGenetron Health Announces Shareholders’ Approval of Merger AgreementFebruary 21, 2024 | globenewswire.comGenetron Health Announces Shareholders' Approval of Merger AgreementFebruary 14, 2024 | fool.comGenetron (NASDAQ: GTH)April 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 14, 2024 | wsj.comGenetron Holdings Ltd. ADRJanuary 17, 2024 | finance.yahoo.comGenetron Health to Hold Extraordinary General Meeting of ShareholdersJanuary 9, 2024 | seekingalpha.comAlbertsons-Kroger And 15 Other Merger Arbitrage Opportunities With Wide SpreadsJanuary 9, 2024 | seekingalpha.comGenetron Holdings' Enticing Arbitrage ReturnNovember 24, 2023 | morningstar.comGenetron Holdings Ltd ADR GTHOctober 12, 2023 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Enters into Definitive Merger Agreement for Going Private TransactionOctober 12, 2023 | msn.comStocks Rise Before the Open as U.S. Inflation Data LoomsOctober 12, 2023 | msn.comStocks Climb Before the Open as Bond Yields Fall, U.S. Inflation Data LoomsOctober 11, 2023 | finance.yahoo.comGenetron Health Enters into Definitive Merger Agreement for Going Private TransactionMay 24, 2023 | msn.comGenetron Health receives Nasdaq notice for non-complianceMarch 27, 2023 | msn.comAmerican Depositary Receipts of Asian Stocks Lower Amid Banking Sector WorriesJanuary 18, 2023 | finance.yahoo.comGenetron Health Regains Compliance With Nasdaq Minimum Bid Price RequirementDecember 28, 2022 | msn.comEarlier US Stock Market Losses Weighed on Asian EquitiesNovember 7, 2022 | finance.yahoo.comGenetron Health Announces Receipt of Notification from NasdaqOctober 19, 2022 | seekingalpha.comGTH Genetron Holdings LimitedOctober 12, 2022 | finance.yahoo.comGenetron Health Reports Unaudited Second Quarter 2022 Financial ResultsSeptember 20, 2022 | reuters.comGenetron Holdings LtdSeptember 2, 2022 | finance.yahoo.comGenetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special CommitteeSee More Headlines Receive GTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/23/2021Today4/24/2024Next Earnings (Estimated)5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolNASDAQ:GTH CUSIPN/A CIK1782594 Webwww.genetronhealth.com Phone86-10-5090-7500FaxN/AEmployees993Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$94.34 million Price / Sales1.35 Cash FlowN/A Price / Cash FlowN/A Book Value$2.63 per share Price / Book1.53Miscellaneous Outstanding Shares31,620,000Free FloatN/AMarket Cap$127.43 million OptionableNot Optionable Beta0.51 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Sizhen Wang (Age 47)Co-Founder, CEO & Chairman Dr. Wei-Wu He Ph.D. (Age 59)Co-Founder & Chairman Emeritus Dr. Hai Yan M.D. (Age 56)Ph.D., Co-Founder, Chief Scientific Officer & Director Mr. Ce Xu (Age 42)Chief Financial Officer Ms. Victoria LeiChief Operating OfficerDr. Yuchen Jiao M.D. (Age 46)Ph.D., Chief Technology Officer Mr. Yong Liang (Age 50)Chief Human Resources Officer Dr. Yun-Fu Hu Ph.D. (Age 61)Chief Medical Officer Ms. Lily LiuChief Commercial OfficerMore ExecutivesKey CompetitorsOutset MedicalNASDAQ:OMVor BiopharmaNYSE:VORNGM BiopharmaceuticalsNASDAQ:NGMFitLife BrandsNASDAQ:FTLFOmega TherapeuticsNASDAQ:OMGAView All CompetitorsInstitutional OwnershipBlack Maple Capital Management LPBought 158,112 shares on 2/15/2024Ownership: 0.500%Crystalline Management Inc.Bought 113,395 shares on 2/12/2024Ownership: 0.359%Robeco Institutional Asset Management B.V.Sold 182,589 shares on 2/8/2024Ownership: 0.289%Vivo Capital LLCSold 5,416,118 shares on 2/7/2024Ownership: 8.564%Yong Rong HK Asset Management LtdSold 214,722 shares on 2/6/2024Ownership: 0.340%View All Institutional Transactions GTH Stock Analysis - Frequently Asked Questions How have GTH shares performed in 2024? Genetron's stock was trading at $3.68 at the start of the year. Since then, GTH stock has increased by 9.5% and is now trading at $4.03. View the best growth stocks for 2024 here. When is Genetron's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our GTH earnings forecast. How were Genetron's earnings last quarter? Genetron Holdings Limited (NASDAQ:GTH) posted its quarterly earnings data on Sunday, May, 23rd. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.30. The business earned $14.05 million during the quarter. Read the conference call transcript. When did Genetron's stock split? Shares of Genetron reverse split before market open on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. When did Genetron IPO? Genetron (GTH) raised $162 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 13,000,000 shares at $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers. How do I buy shares of Genetron? Shares of GTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GTH) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetron Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
